WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience Discover www.zeiss.de/functionality
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, February 27, 2008, 28(9):2212-2220; doi:10.1523/JNEUROSCI.4354-07.2008

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shinzawa, K.
Right arrow Articles by Tsujimoto, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shinzawa, K.
Right arrow Articles by Tsujimoto, Y.

 Previous Article  |  Next Article 

Neurobiology of Disease
Neuroaxonal Dystrophy Caused by Group VIA Phospholipase A2 Deficiency in Mice: A Model of Human Neurodegenerative Disease

Koei Shinzawa,1 Hisae Sumi,2 Masahito Ikawa,3 Yosuke Matsuoka,1 Masaru Okabe,3 Saburo Sakoda,2 and Yoshihide Tsujimoto1

1Department of Medical Genetics, Laboratory of Molecular Genetics and Solution-Oriented Research for Science and Technology, Japan Science and Technology Agency, and 2Department of Neurology, Osaka University Medical School, Osaka 565-0871, Japan, and 3Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan

Correspondence should be addressed to Yoshihide Tsujimoto, Laboratory of Molecular Genetics, Osaka University Medical School, Room B8, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan. Email: tsujimot{at}gene.med.osaka-u.ac.jp

Calcium-independent group VIA phospholipase A2 (iPLA2β) is considered to play a role in signal transduction and maintenance of homeostasis or remodeling of membrane phospholipids. A role of iPLA2β has been suggested in various physiological and pathological processes, including immunity, chemotaxis, and cell death, but the details remain unclear. Accordingly, we investigated mice with targeted disruption of the iPLA2β gene. iPLA2β–/– mice developed normally and grew to maturity, but all showed evidence of severe motor dysfunction, including a hindlimb clasping reflex during tail suspension, abnormal gait, and poor performance in the hanging wire grip test. Neuropathological examination of the nervous system revealed widespread degeneration of axons and/or synapses, accompanied by the presence of numerous spheroids (swollen axons) and vacuoles. These findings provide evidence that impairment of iPLA2β causes neuroaxonal degeneration, and indicate that the iPLA2β–/– mouse is an appropriate animal model of human neurodegenerative diseases associated with mutations of the iPLA2β gene, such as infantile neuroaxonal dystrophy and neurodegeneration with brain iron accumulation.

Key words: phospholipase; neurodegeneration; neuroaxonal dystrophy; knock-out mouse; iPLA2; spheroid


Received Nov. 22, 2006; revised Jan. 15, 2008; accepted Jan. 17, 2008.

Correspondence should be addressed to Yoshihide Tsujimoto, Laboratory of Molecular Genetics, Osaka University Medical School, Room B8, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan. Email: tsujimot{at}gene.med.osaka-u.ac.jp






-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2008 by Society for Neuroscience ONLINE ISSN: 1529-2401
-